125 related articles for article (PubMed ID: 34019044)
1. Selenium-driven enhancement of synergistic cancer chemo-/radiotherapy by targeting nanotherapeutics.
Liu X; Yuan Z; Tang Z; Chen Q; Huang J; He L; Chen T
Biomater Sci; 2021 Jul; 9(13):4691-4700. PubMed ID: 34019044
[TBL] [Abstract][Full Text] [Related]
2. Dual-function nanosystem for synergetic cancer chemo-/radiotherapy through ROS-mediated signaling pathways.
He L; Lai H; Chen T
Biomaterials; 2015 May; 51():30-42. PubMed ID: 25770995
[TBL] [Abstract][Full Text] [Related]
3. Folic acid modified lipid-bilayer coated mesoporous silica nanoparticles co-loading paclitaxel and tanshinone IIA for the treatment of acute promyelocytic leukemia.
Li Z; Zhang Y; Zhu C; Guo T; Xia Q; Hou X; Liu W; Feng N
Int J Pharm; 2020 Aug; 586():119576. PubMed ID: 32603839
[TBL] [Abstract][Full Text] [Related]
4. Selenium promotes immunogenic radiotherapy against cervical cancer metastasis through evoking P53 activation.
Xu Y; Lai H; Pan S; Pan L; Liu T; Yang Z; Chen T; Zhu X
Biomaterials; 2024 Mar; 305():122452. PubMed ID: 38154440
[TBL] [Abstract][Full Text] [Related]
5. Rational Design of Cancer-Targeted Selenadiazole Derivative as Efficient Radiosensitizer for Precise Cancer Therapy.
Zeng D; Deng S; Sang C; Zhao J; Chen T
Bioconjug Chem; 2018 Jun; 29(6):2039-2049. PubMed ID: 29771500
[TBL] [Abstract][Full Text] [Related]
6. Preparation and identification of multifunctional mesoporous silica nanoparticles for in vitro and in vivo dual-mode imaging, theranostics, and targeted tracking.
Chan MH; Lin HM
Biomaterials; 2015 Apr; 46():149-58. PubMed ID: 25678124
[TBL] [Abstract][Full Text] [Related]
7. Folic acid (FA)-conjugated mesoporous silica nanoparticles combined with MRP-1 siRNA improves the suppressive effects of myricetin on non-small cell lung cancer (NSCLC).
Song Y; Zhou B; Du X; Wang Y; Zhang J; Ai Y; Xia Z; Zhao G
Biomed Pharmacother; 2020 May; 125():109561. PubMed ID: 32106385
[TBL] [Abstract][Full Text] [Related]
8. Cancer-Targeted Selenium Nanoparticles Sensitize Cancer Cells to Continuous γ Radiation to Achieve Synergetic Chemo-Radiotherapy.
Chan L; He L; Zhou B; Guan S; Bo M; Yang Y; Liu Y; Liu X; Zhang Y; Xie Q; Chen T
Chem Asian J; 2017 Dec; 12(23):3053-3060. PubMed ID: 28892302
[TBL] [Abstract][Full Text] [Related]
9. Functionalized Selenium Nanosystem as Radiation Sensitizer of
Yang Y; Xie Q; Zhao Z; He L; Chan L; Liu Y; Chen Y; Bai M; Pan T; Qu Y; Ling L; Chen T
ACS Appl Mater Interfaces; 2017 Aug; 9(31):25857-25869. PubMed ID: 28718286
[TBL] [Abstract][Full Text] [Related]
10. A smart pH-responsive nano-carrier as a drug delivery system for the targeted delivery of ursolic acid: suppresses cancer growth and metastasis by modulating P53/MMP-9/PTEN/CD44 mediated multiple signaling pathways.
Jiang K; Chi T; Li T; Zheng G; Fan L; Liu Y; Chen X; Chen S; Jia L; Shao J
Nanoscale; 2017 Jul; 9(27):9428-9439. PubMed ID: 28660943
[TBL] [Abstract][Full Text] [Related]
11. Targeted anticancer prodrug with mesoporous silica nanoparticles as vehicles.
Fan J; Fang G; Wang X; Zeng F; Xiang Y; Wu S
Nanotechnology; 2011 Nov; 22(45):455102. PubMed ID: 22019849
[TBL] [Abstract][Full Text] [Related]
12. pH-Sensitive Delivery Vehicle Based on Folic Acid-Conjugated Polydopamine-Modified Mesoporous Silica Nanoparticles for Targeted Cancer Therapy.
Cheng W; Nie J; Xu L; Liang C; Peng Y; Liu G; Wang T; Mei L; Huang L; Zeng X
ACS Appl Mater Interfaces; 2017 Jun; 9(22):18462-18473. PubMed ID: 28497681
[TBL] [Abstract][Full Text] [Related]
13. Cancer-targeted and intracellular delivery of Bcl-2-converting peptide with functional macroporous silica nanoparticles for biosafe treatment.
Wu Y; Ge P; Xu W; Li M; Kang Q; Zhang X; Xie J
Mater Sci Eng C Mater Biol Appl; 2020 Mar; 108():110386. PubMed ID: 31923940
[TBL] [Abstract][Full Text] [Related]
14. Selenadiazole derivatives as theranostic agents for simultaneous cancer chemo-/radiotherapy by targeting thioredoxin reductase.
He L; Ji S; Lai H; Chen T
J Mater Chem B; 2015 Nov; 3(42):8383-8393. PubMed ID: 32262891
[TBL] [Abstract][Full Text] [Related]
15. Etoposide encased folic acid adorned mesoporous silica nanoparticles as potent nanovehicles for enhanced prostate cancer therapy: synthesis, characterization, cellular uptake and biodistribution.
Saroj S; Rajput SJ
Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S1115-S1130. PubMed ID: 30669865
[TBL] [Abstract][Full Text] [Related]
16. Rational design of cancer-targeted BSA protein nanoparticles as radiosensitizer to overcome cancer radioresistance.
Huang Y; Luo Y; Zheng W; Chen T
ACS Appl Mater Interfaces; 2014; 6(21):19217-28. PubMed ID: 25314331
[TBL] [Abstract][Full Text] [Related]
17. Targeted delivery of quercetin loaded mesoporous silica nanoparticles to the breast cancer cells.
Sarkar A; Ghosh S; Chowdhury S; Pandey B; Sil PC
Biochim Biophys Acta; 2016 Oct; 1860(10):2065-75. PubMed ID: 27392941
[TBL] [Abstract][Full Text] [Related]
18. Folic acid-hydrophilic polymer coated mesoporous silica nanoparticles target doxorubicin delivery.
Al-Nadaf AH; Dahabiyeh LA; Jawarneh S; Bardaweel S; Mahmoud NN
Pharm Dev Technol; 2021 Jun; 26(5):582-591. PubMed ID: 33729906
[TBL] [Abstract][Full Text] [Related]
19. Efficacy-shaping nanomedicine by loading Calcium Peroxide into Tumor Microenvironment-responsive Nanoparticles for the Antitumor Therapy of Prostate Cancer.
Wu D; Zhu ZQ; Tang HX; Shi ZE; Kang J; Liu Q; Qi J
Theranostics; 2020; 10(21):9808-9829. PubMed ID: 32863961
[No Abstract] [Full Text] [Related]
20. A Dual-Model Imaging Theragnostic System Based on Mesoporous Silica Nanoparticles for Enhanced Cancer Phototherapy.
Huang C; Zhang Z; Guo Q; Zhang L; Fan F; Qin Y; Wang H; Zhou S; Ou-Yang W; Sun H; Leng X; Pan X; Kong D; Zhang L; Zhu D
Adv Healthc Mater; 2019 Oct; 8(19):e1900840. PubMed ID: 31512403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
